When Is Recalcitrant Pyoderma Gangrenosum Truly Recalcitrant?

Journal of Cutaneous Medicine and Surgery

Volumn 7, Issue 5, 2003, Pages 387-389

  Barnabé, Cheryl ^a   Hurst, Lorne ^a,b   Alowami, Salem ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b 1602 Medical Arts Building ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CALCIUM ALGINATE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

AGED; ANTIBIOTIC THERAPY; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LEG ULCER; PRIORITY JOURNAL; PYODERMA; PYODERMA GANGRENOSUM; REVIEW; SKIN BIOPSY; STEROID THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; WOUND DRESSING;

AGED; DEMOGRAPHY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PYODERMA GANGRENOSUM; TREATMENT FAILURE;

EID: 0344629144     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-002-0157-7     Document Type: Review

References (11)

1. De Imus G, Golomb C, Wilkel C, et al. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 2001; 44:61-66.
2. Weenig RH, Davis MDP, Dahl PR, et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002; 347:1412-1418.
3. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46:228-241.
4. Reich K, Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol 1998; 139:755-757.
5. D'Inca R, Fagiuoli S, Sturniolo GC. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporin. Ann Intern Med 1998; 1289:783-784.
6. Weichert G, Sauder DN. Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum. J Am Acad Dennatol 1998; 38(4 Pt 1):648-650.
7. Lyon CC, Kirby B, Griffiths CEM. Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. Br J Dermatol 1999; 140:562-564.
8. Jolles S, Niclasse S, Benson E. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. Br J Dermatol 1999; 140:564-565.
9. Richter-Hintz D, Schuppe HC, Homey B, et al. Topical tacrolimus is effective in the treatment of pyoderma gangrenosum. J Am Acad Dermatol 2000; 42(2 Pt 1):304-305.
10. Nousari HC, Lynch W, Anhalt GJ, et al. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. J Am Acad Dermatol 1998; 134:1509-1511.
11. Gilmour E, Stewart DG. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis. Br J Dermatol 2001; 144:397-400.